Xcout IntelSign inSubscribe

4DMEDICAL LIMITED competitors & alternatives

4DXHealth Care Equipment & ServicesCarlton, Australia

The 12 closest competitors and alternatives to 4DMEDICAL LIMITED among health care equipment & services companies — ranked by similarity to what 4DMEDICAL LIMITED actually does, not by market-cap band.

$1.6BMarket cap
124Employees
12Competitors listed

Subscribe to see 4DMEDICAL LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About 4DMEDICAL LIMITED

4DMedical Ltd is an Australian medical technology company based in Melbourne, Victoria, specializing in respiratory imaging and software solutions.

4DMEDICAL LIMITED at a glance

4DMEDICAL LIMITED is a health care equipment & services company headquartered in Carlton, Australia. It is publicly listed (4DX) with a market capitalisation of $1.6B. Xcout tracks 20 named people at 4DMEDICAL LIMITED, including Andreas Fouras, PhD (Managing Director & CEO).

4DMEDICAL LIMITED leadership

  • Andreas Fouras, PhDManaging Director & CEO
  • Julian SuttonChief Financial Officer
  • Greg Mogel, MD, FACRChief Medical Officer
  • Matt TuckerChief Commercial Officer
  • Aidan Jamison, PhDSVP, Engineering
  • David HannesSVP, Global Business Development

14 more named people on record for 4DMEDICAL LIMITED, with roles, board committees and tenure — see the full roster →

Top 12 4DMEDICAL LIMITED competitors

Ranked by semantic similarity — how close each company is to 4DMEDICAL LIMITED by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

RESONANCE HEALTH LIMITEDRHT · Health Care Equipment & ServicesBurswood, Australia
63% matchPublic

Similar health care equipment & services company

Resonance Health Limited is a global provider of healthcare technology and services, specializing in the design, development, and production of software-as-medical devices. The company serves markets across the Asia Pacific, Americas, Europe, Middle East, and Africa. Its portfolio of non-invasive, MRI-based diagnostic tools includes FerriScan, a system for quantifying liver iron concentration (LIC); FerriSmart, leveraging artificial intelligence (AI) for automated, real-time assessment of LIC; HepaFat-AI, an AI-driven solution for real-time, multi-metric liver fat quantification; CardiacT2, which provides dual analysis in conjunction with FerriScan to evaluate cardiac iron accumulation; HepaFat-Scan, a non-invasive MRI method for assessing liver fat within tissue; and LiverSmart, a comprehensive non-invasive MRI device integrating FerriSmart and HepaFat-AI for a unified report. The company further extends its offerings to include quantitative imaging measurements and Contract Research Organization (CRO) services, encompassing rigorous image analysis, imaging charter development, robust project and data management, proactive issue resolution, site tracking with clinical trial progress reports, and streamlined data flow coordination. They also provide comprehensive biomarker services, covering analysis of blood, urine, and protein analytes, alongside RNA, DNA, and genotyping. Their support for multinational and multicenter clinical trials extends to protocol development, subject inclusion/exclusion criteria assessment, dose modification strategies, new therapy safety profile evaluations, and establishing primary and secondary endpoints for drug efficacy. Additionally, they supply phantoms crucial for MRI machine calibration. Its client base includes clinicians, who utilize their solutions for managing human diseases, and pharmaceutical and therapeutic companies engaged in clinical research. Established in 1987, Resonance Health Limited maintains its headquarters in Burswood, Australia.

Market cap$18.7M
Employees18
RESONANCE HEALTH LIMITED competitors & alternatives →
Pulmonx CorporationLUNG · Medical DevicesRedwood City, United States
63% matchPublic

Medical Devices

Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Platform, a cloud-based service that conducts quantitative computed tomography (CT) analysis. This platform delivers vital data concerning emphysema destruction, fissure completeness, and lobar volume, thereby aiding clinicians in accurately identifying the most suitable target lobes for treatment with Zephyr Valves. Pulmonx serves emphysema patients across a broad international footprint, encompassing the United States, Europe, the Middle East, Africa, and the Asia-Pacific region. The company, which changed its name from Pulmonx to Pulmonx Corporation in December 2013, was originally incorporated in 1995 and maintains its corporate headquarters in Redwood City, California.

Market cap$76.2M
Employees296
Pulmonx Corporation competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of 4DMEDICAL LIMITED and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for 4DMEDICAL LIMITEDand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →